Safety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Results from the NIVOREN GETUG-AFU 26 study.

被引：9
|
作者：
Albiges, Laurence
Negrier, Sylvie
Dalban, Cecile
Gravis, Gwenaelle
Chevreau, Christine
Oudard, Stephane
Laguerre, Brigitte
Barthelemy, Philippe
Borchiellini, Delphine
Gross-Goupil, Marine
Geoffrois, Lionnel
Brihoum, Meryem
Escudier, Bernard
机构：
[1] Univ Paris Sud, Gustave Roussy Inst Oncol, Villejuif, France
[2] Ctr Leon Berard, Lyon, France
[3] Inst Paoli Calmettes, Marseille, France
[4] IUCT Oncopole Inst Claudius Regaud, Toulouse, France
[5] AP HP, Hop Europeen Georges Pompidou, Paris, France
[6] Ctr Eugene Marquis, Rennes, France
[7] Hopitaux Univ Strasbourg, Strasbourg, France
[8] Ctr Antoine Lacassagne, Nice, France
[9] Ctr Hosp Univ St Andre, Bordeaux, France
[10] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France
[11] UNICANCER, Paris, France
[12] Gustave Roussy Canc Campus, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.577
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
577
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Safety and efficacy of nivolumab in older patients (pts) with renal cell carcinoma: Results of a sub-group analysis of the GETUG-AFU 26 NIVOREN multicenter phase II study.
    Mourey, Loic
    Dalban, Cecile
    Negrier, Sylvie
    Chevreau, Christine
    Gravis, Gwenaelle
    Thibault, Constance
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Gross-Goupil, Marine
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Joly, Florence
    Ladoire, Sylvain
    Tantot, Florence
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [12] The impact of baseline peripheral cytokines on survival in metastatic clear cell renal cell carcinoma (RCC) treated with nivolumab: NIVOREN GETUG-AFU 26 Translational study.
    Carril, Lucia
    Naigeon, Marie
    Dalban, Cecile
    Desnoyer, Aude
    Rioux-Leclercq, Nathalie
    Sautes-Fridman, Catherine
    Meylan, Maxime
    Vano, Yann-Alexandre
    Beusenlick, Benoit
    Chouaib, Salem
    de Oliveira, Caroline
    Tantot, Florence
    Escudier, Bernard
    Albiges, Laurence
    Chaput, Nathalie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [13] Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study
    Velev, Maud
    Dalban, Cecile
    Chevreau, Christine
    Gravis, Gwenaelle
    Negrier, Sylvie
    Laguerre, Brigitte
    Gross-Goupil, Marine
    Ladoire, Sylvain
    Borchiellini, Delphine
    Geoffrois, Lionnel
    Joly, Florence
    Priou, Frank
    Barthelemy, Philippe
    Laramas, Mathieu
    Narciso, Berangere
    Thiery-Vuillemin, Antoine
    Berdah, Jean-Francois
    Ferrari, Victoria
    Thomas, Quentin Dominique
    Mione, Cecile
    Curcio, Hubert
    Oudard, Stephane
    Tantot, Florence
    Escudier, Bernard
    Chabaud, Sylvie
    Albiges, Laurence
    Thibault, Constance
    EUROPEAN JOURNAL OF CANCER, 2023, 182 : 66 - 76
  • [14] Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG-AFU 26 NIVOREN
    Guilhem-Ducleon, Guillemette
    Dalban, Cecile
    Negrier, Sylvie
    Gravis, Gwenaelle
    Laguerre, Brigitte
    Chevreau, Christine
    Oudard, Stephane
    Barthelemy, Philippe
    Ladoire, Sylvain
    Boughalem, Elouen
    Borchiellini, Delphine
    Linassier, Claude
    Nenan, Soazig
    Flippot, Ronan
    Albiges, Laurence
    Goupil, Marine Gross
    CLINICAL GENITOURINARY CANCER, 2023, 21 (06) : 643 - 652
  • [15] Validation of the lung immune prognostic index (LIPI) in patients with metastatic renal cell carcinoma treated with nivolumab in the GETUG-AFU 26 NIVOREN trial
    Lavaud, Pernelle
    Dalban, Cecile
    Negrier, Sylvie
    Chevreau, Christine
    Gravis, Gwenaelle
    Oudard, Stephane
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Goupil, Marine Gross
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Joly, Florence
    Ladoire, Sylvain
    Tantot, Florence
    Mezquita, Laura
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [16] NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab
    Ajuria, L. Carril
    Naigeon, M.
    Dalban, C.
    Desnoyer, A.
    Rioux-Leclercq, N.
    Sautes-Fridman, C.
    Meylan, M.
    Vano, Y.
    Beuselinck, B.
    Chouaib, S.
    de Oliveira, C.
    Tantot, F.
    Escudier, B.
    Albiges, L.
    Chaput, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S704 - S705
  • [17] Association of statins and nivolumab activity in patients with metastatic renal cell carcinoma (mRCC): Results from the phase II nivoren-GETUG AFU 26 trial.
    Colomba, Emeline
    Flippot, Ronan
    Dalban, Cecile
    Negrier, Sylvie
    Chevreau, Christine
    Gravis, Gwenaelle
    Oudard, Stephane
    Laguerre, Brigitte
    Barthelemy, Philippe
    Goupil, Marine Gross
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Joly, Florence
    Ladoire, Sylvain
    Tantot, Florence
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [18] Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial
    Flippot, R.
    Dalban, C.
    Laguerre, B.
    Borchiellini, D.
    Gravis, G.
    Negrier, S.
    Chevreau, C. M.
    Joly, F.
    Geoffrois, L.
    Ladoire, S.
    Mahammedi, H.
    Tantot, F.
    Escudier, B.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2018, 29 : 306 - 306
  • [19] Baseline cytokine levels according to the line of treatment in patients with metastatic clear cell renal cell carcinoma treated with nivolumab: NIVOREN GETUG-AFU 26 translational study
    Rainho, L. T.
    Albiges, L.
    Flippot, R.
    Ajuria, L. Carril
    Dalban, C.
    Escudier, B.
    Naigeon, M.
    Desnoyer, A.
    Teixeira, M.
    Chaput-Gras, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S1027 - S1027
  • [20] Baseline circulating soluble factors as predictors of immune-related adverse events (irAEs) in patients (pts) with metastatic clear cell renal carcinoma (mRCC) treated with nivolumab: A translational NIVOREN GETUG-AFU 26 study.
    Carril-Ajuria, Lucia
    Naigeon, Marie
    Dalban, Cecile
    Desnoyer, Aude
    Rioux-Leclercq, Nathalie
    Sautes-Fridman, Catherine
    Meylan, Maxime
    Vano, Yann-Alexandre
    Beusenlick, Benoit
    Chouaib, Salem
    de Oliveira, Caroline
    Tantot, Florence
    Flippot, Ronan
    Escudier, Bernard
    Albiges, Laurence
    Chaput, Nathalie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345